Severe sepsis and septic shock: Management and performance improvement

Virulence

Volumn 5, Issue 1, 2014, Pages 190-199

  Schorr, Christa A ^a   Zanotti, Sergio ^a   Dellinger, R Phillip ^a  

^a Department of Anesthesiology   (United States)

Author keywords

Guidelines; Performance improvement; Resuscitation; Sepsis bundles; Severe sepsis

Indexed keywords

ALBUMIN; ANTIINFECTIVE AGENT; CHLORHEXIDINE GLUCONATE; DALTEPARIN; DOBUTAMINE; DOPAMINE; HYDROCORTISONE; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; NORADRENALIN; VASOPRESSIN; BIOLOGICAL MARKER; STEROID;

ADULT RESPIRATORY DISTRESS SYNDROME; BLOOD CULTURE; CLINICAL EDUCATION; CONTINUOUS INFUSION; CRYSTALLOID; DEEP VEIN THROMBOSIS; ENTERIC FEEDING; HEMODYNAMICS; HUMAN; INFECTION; LACTATE BLOOD LEVEL; MEAN ARTERIAL PRESSURE; PERFUSION; PRACTICE GUIDELINE; REVIEW; SEPSIS; SEPTIC SHOCK; STRESS ULCER; THROMBOCYTE TRANSFUSION; BACTERIAL INFECTION; BLOOD; INTENSIVE CARE; METHODOLOGY; MORTALITY; PERFORMANCE IMPROVEMENT; RESUSCITATION; SEPSIS BUNDLES; SEVERE SEPSIS; TREATMENT OUTCOME;

GUIDELINES; PERFORMANCE IMPROVEMENT; RESUSCITATION; SEPSIS BUNDLES; SEVERE SEPSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CRITICAL CARE; HUMANS; SHOCK, SEPTIC; STEROIDS; TREATMENT OUTCOME;

EID: 84891672214     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.27409     Document Type: Review

References (126)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-10; PMID:11445675; http://dx.doi.org/10.1097/00003246-200107000-00002.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-54; PMID:12700374; http://dx.doi.org/10.1056/NEJMoa022139.
3. Cinel I, Dellinger RP. Current treatment of severe sepsis. Curr Infect Dis Rep 2006; 8:358-65; PMID:16934194; http://dx.doi.org/10.1007/s11908-006-0046-0.
4. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al.; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-73; PMID:15090974; http://dx.doi.org/10.1097/01.CCM.0000117317.18092.E4.
5. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al.; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327; PMID:18158437; http://dx.doi.org/10.1097/01.CCM.0000298158.12101.41.
6. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637; PMID:23353941; http://dx.doi.org/10.1097/CCM.0b013e31827e83af
7. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007; 35:1244-50; PMID:17414736; http://dx.doi.org/10.1097/01.CCM.0000261890.41311.E9.
8. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-77; PMID:11794169; http://dx.doi.org/10.1056/NEJMoa010307.
9. Early Goal-Directed Therapy Collaborative Group of Zhejiang Province. [The effect of early goal-directed therapy on treatment of critical patients with severe sepsis/septic shock: a multi-center, prospective, randomized, controlled study] [in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2010; 22:331-4; PMID:20594464.
10. Kortgen A, Niederprüm P, Bauer M. Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Crit Care Med 2006; 34:943-9; PMID:16484902; http://dx.doi.org/10.1097/01.CCM.0000206112.32673.D4.
11. Sebat F, Johnson D, Musthafa AA, Watnik M, Moore S, Henry K, Saari M. A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. Chest 2005; 127:1729-43; PMID:15888853; http://dx.doi.org/10.1378/chest.127.5.1729.
12. Shapiro NI, Howell MD, Talmor D, Lahey D, Ngo L, Buras J, Wolfe RE, Weiss JW, Lisbon A. implementation and outcomes of the multiple urgent sepsis therapies (MUST) protocol. Crit Care Med 2006; 34:1025-32; PMID:16484890; http://dx.doi.org/10.1097/01.CCM.0000206104.18647.A8.
13. Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, Murphy T, Prentice D, Ruoff BE, Kollef MH. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 2006; 34:2707-13; PMID:16943733; http://dx.doi.org/10.1097/01.CCM.0000241151.25426.D7.
14. Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, Edwards J, Cho TW, Wittlake WA. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 2007; 35:1105-12; PMID:17334251; http://dx.doi.org/10.1097/01.CCM.0000259463.33848.3D
15. Trzeciak S, Dellinger RP, Abate NL, Cowan RM, Stauss M, Kilgannon JH, Zanotti S, Parrillo JE. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 2006; 129:225-32; PMID:16478835; http://dx.doi.org/10.1378/chest.129.2.225.
16. Magder S. Central venous pressure: A useful but not so simple measurement. Crit Care Med 2006; 34:2224-7; PMID:16763509; http://dx.doi.org/10.1097/01.CCM.0000227646.98423.98.
17. Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med 2006; 34:1333-7; PMID:16557164; http://dx.doi.org/10.1097/01.CCM.0000214677.76535.A5.
18. Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki LM, Pettilä V. Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005; 31:1066-71; PMID:15973520; http://dx.doi.org/10.1007/s00134-005-2688-z
19. LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28:2729-32; PMID:10966242; http://dx.doi.org/10.1097/00003246-200008000-00007.
20. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-77; PMID:11794169; http://dx.doi.org/10.1056/NEJMoa010307.
21. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010; 303:739-46; PMID:20179283; http://dx.doi.org/10.1001/jama.2010.158.
22. Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, Willemsen SP, Bakker J; LACTATE study group. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010; 182:752-61; PMID:20463176; http://dx.doi.org/10.1164/rccm.200912-1918OC
23. Moore LJ, Jones SL, Kreiner LA, McKinley B, Sucher JF, Todd SR, Turner KL, Valdivia A, Moore FA. Validation of a screening tool for the early identification of sepsis. J Trauma 2009; 66:1539-46, discussion 1546-7; PMID:19509612; http://dx.doi.org/10.1097/TA.0b013e3181a3ac4b
24. Evaluation for Severe Sepsis Screening Tool, Institute for Healthcare Improvement (IHI). http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis/Tools/EvaluationforSevereSepsisScreeningTool.htm
25. Evaluation for severe sepsis screening tool. http://www.survivingsepsis.org/SiteCollectionDocuments/ScreeningTool.pdf
26. Weinstein MP, Reller LB, Murphy JR, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5:35-53; PMID:6828811; http://dx.doi.org/10.1093/clinids/5.1.35.
27. Blot F, Schmidt E, Nitenberg G, Tancrède C, Leclercq B, Laplanche A, Andremont A. Earlier positivity of central-venous-versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998; 36:105-9; PMID:9431930.
28. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, Kesecioglu J. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003; 362:1011-6; PMID:14522530; http://dx.doi.org/10.1016/S0140-6736(03)14409-1.
29. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360:20-31; PMID:19118302; http://dx.doi.org/10.1056/NEJMoa0800394.
30. Cuthbertson BH, Francis J, Campbell MK, MacIntyre L, Seppelt I, Grimshaw J; SuDDICU study groups. A study of the perceived risks, benefits and barriers to the use of SDD in adult critical care units (the SuDDICU study). Trials 2010; 11:117; PMID:21129208; http://dx.doi.org/10.1186/1745-6215-11-117.
31. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-96; PMID:16625125; http://dx.doi.org/10.1097/01.CCM.0000217961.75225.E9.
32. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49:3640-5; PMID:16127033; http://dx.doi.org/10.1128/AAC.49.9.3640-3645.2005.
33. Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR. Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt) 2005; 6:41-54; PMID:15865550; http://dx.doi.org/10.1089/sur.2005.6.41.
34. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-86; PMID:9845853; http://dx.doi.org/10.1046/j.1365-2796.1998.00379.x
35. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-55; PMID:10893372; http://dx.doi.org/10.1378/chest.118.1.146.
36. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, et al.; Surviving Sepsis Campaign. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010; 38:367-74; PMID:20035219; http://dx.doi.org/10.1097/CCM.0b013e3181cb0cdc
37. Micek ST, Welch EC, Khan J, Pervez M, Doherty JA, Reichley RM, Kollef MH. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother 2010; 54:1742-8; PMID:20160050; http://dx.doi.org/10.1128/AAC.01365-09.
38. Al-Hasan MN, Wilson JW, Lahr BD, Thomsen KM, Eckel-Passow JE, Vetter EA, Tleyjeh IM, Baddour LM. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gramnegative bacilli. Antimicrob Agents Chemother 2009; 53:1386-94; PMID:19164144; http://dx.doi.org/10.1128/AAC.01231-08.
39. Martin-Loeches I, Lisboa T, Rodriguez A, Putensen C, Annane D, Garnacho-Montero J, Restrepo MI, Rello J. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 2010; 36:612-20; PMID:19953222; http://dx.doi.org/10.1007/s00134-009-1730-y
40. Smith JR, Ariano RE, Toovey S. The use of antiviral agents for the management of severe influenza. Crit Care Med 2010; 38(Suppl):e43-51; PMID:19935416; http://dx.doi.org/10.1097/CCM.0b013e3181c85229.
41. Jimenez MF, Marshall JC; International Sepsis Forum. Source control in the management of sepsis. Intensive Care Med 2001; 27(Suppl 1):S49-62; PMID:11307370; http://dx.doi.org/10.1007/PL00003797.
42. Boyer A, Vargas F, Coste F, Saubusse E, Castaing Y, Gbikpi-Benissan G, Hilbert G, Gruson D. Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 2009; 35:847-53; PMID:19099288; http://dx.doi.org/10.1007/s00134-008-1373-4.
43. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-56; PMID:15163774; http://dx.doi.org/10.1056/NEJMoa040232.
44. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012; 16:R94; PMID:22624531; http://dx.doi.org/10.1186/cc11358.
45. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, et al.; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124-34; PMID:22738085; http://dx.doi.org/10.1056/NEJMoa1204242.
46. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, et al.; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-11; PMID:23075127; http://dx.doi.org/10.1056/NEJMoa1209759.
47. Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 2011; 39:386-91; PMID:21248514; http://dx.doi.org/10.1097/CCM.0b013e3181ffe217.
48. Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28:2758-65; PMID:10966247; http://dx.doi.org/10.1097/00003246-200008000-00012.
49. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362:779-89; PMID:20200382; http://dx.doi.org/10.1056/NEJMoa0907118.
50. De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med 2012; 40:725-30; PMID:22036860; http://dx.doi.org/10.1097/CCM.0b013e31823778ee
51. Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, Troché G, Ricard JD, Nitenberg G, Papazian L, et al.; CATS Study Group. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007; 370:676-84; PMID:17720019; http://dx.doi.org/10.1016/S0140-6736(07)61344-0.
52. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J; CAT Study investigators. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008; 34:2226-34; PMID:18654759; http://dx.doi.org/10.1007/s00134-008-1219-0.
53. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, et al.; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-87; PMID:18305265; http://dx.doi.org/10.1056/NEJMoa067373.
54. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J; Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lowdose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet 2000; 356:2139-43; PMID:11191541; http://dx.doi.org/10.1016/S0140-6736(00)03495-4.
55. Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-71; PMID:12186604; http://dx.doi.org/10.1001/jama.288.7.862.
56. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-32; PMID:10321661; http://dx.doi.org/10.1097/00003246-199904000-00025.
57. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-50; PMID:9559600; http://dx.doi.org/10.1097/00003246-199804000-00010.
58. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, et al.; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-24; PMID:18184957; http://dx.doi.org/10.1056/NEJMoa071366.
59. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R, Keh D, Kupfer Y, Oppert M, Meduri GU. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009; 301:2362-75; PMID:19509383; http://dx.doi.org/10.1001/jama.2009.815.
60. Huh JW, Choi HS, Lim CM, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Hong SB. Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days. Respirology 2011; 16:1088-95; PMID:21726354; http://dx.doi.org/10.1111/j.1440-1843.2011.02018.x
61. Weber-Carstens S, Deja M, Bercker S, Dimroth A, Ahlers O, Kaisers U, Keh D. Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients. Intensive Care Med 2007; 33:730-3; PMID:17325831; http://dx.doi.org/10.1007/s00134-007-0540-3.
62. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167:512-20; PMID:12426230; http://dx.doi.org/10.1164/rccm.200205-446OC
63. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-17; PMID:9971864; http://dx.doi.org/10.1056/NEJM199902113400601.
64. Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, doubleblind, placebo-controlled trial. Crit Care Med 1999; 27:2346-50; PMID:10579246; http://dx.doi.org/10.1097/00003246-199911000-00004.
65. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T; EPO Critical Care Trials Group. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002; 288:2827-35; PMID:12472324; http://dx.doi.org/10.1001/jama.288.22.2827.
66. Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Work Group. Recommendations for the transfusion of plasma and platelets. Blood Transfus 2009; 7:132-50; PMID:19503635.
67. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D; Intensive Care Study of Coagulopathy (ISOC) investigators. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 2011; 15:R108; PMID:21466676; http://dx.doi.org/10.1186/cc10129.
68. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Pénzes I, Kübler A, et al.; KyberSept Trial Study Group. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286:1869-78; PMID:11597289; http://dx.doi.org/10.1001/jama.286.15.1869.
69. Wiedermann CJ, Hoffmann JN, Juers M, Ostermann H, Kienast J, Briegel J, Strauss R, Keinecke HO, Warren BL, Opal SM; KyberSept Investigators. High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety. Crit Care Med 2006; 34:285-92; PMID:16424704; http://dx.doi.org/10.1097/01.CCM.0000194731.08896.99.
70. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122:10-23; PMID:12823341; http://dx.doi.org/10.1046/j.1365-2141.2003.04468.x
71. Alejandria MM, Lansang MA, Dans LF, Mantaring JB. Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev 2002; 1:CD001090; PMID:11869591.
72. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-8; PMID:10793162; http://dx.doi.org/10.1056/NEJM200005043421801.
73. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347-54; PMID:9449727; http://dx.doi.org/10.1056/NEJM199802053380602.
74. Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, Lefrant JY, Prat G, Richecoeur J, Nieszkowska A, et al.; Expiratory Pressure (Express) Study Group. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008; 299:646-55; PMID:18270353; http://dx.doi.org/10.1001/jama.299.6.646.
75. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, Davies AR, Hand LE, Zhou Q, Thabane L, et al.; Lung Open Ventilation Study Investigators. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008; 299:637-45; PMID:18270352; http://dx.doi.org/10.1001/jama.299.6.637.
76. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351:327-36; PMID:15269312; http://dx.doi.org/10.1056/NEJMoa032193.
77. Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, Slutsky AS, Pullenayegum E, Zhou Q, Cook D, et al. Higher vs lower positive endexpiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010; 303:865-73; PMID:20197533; http://dx.doi.org/10.1001/jama.2010.218.
78. Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, Quintel M, Russo S, Patroniti N, Cornejo R, Bugedo G. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006; 354:1775-86; PMID:16641394; http://dx.doi.org/10.1056/NEJMoa052052.
79. Fan E, Wilcox ME, Brower RG, Stewart TE, Mehta S, Lapinsky SE, Meade MO, Ferguson ND. Recruitment maneuvers for acute lung injury: a systematic review. Am J Respir Crit Care Med 2008; 178:1156-63; PMID:18776154; http://dx.doi.org/10.1164/rccm.200802-335OC
80. Mancebo J, Fernández R, Blanch L, Rialp G, Gordo F, Ferrer M, Rodríguez F, Garro P, Ricart P, Vallverdú I, et al. A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med 2006; 173:1233-9; PMID:16556697; http://dx.doi.org/10.1164/rccm.200503-353OC
81. Sud S, Friedrich JO, Taccone P, Polli F, Adhikari NK, Latini R, Pesenti A, Guérin C, Mancebo J, Curley MA, et al. Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med 2010; 36:585-99; PMID:20130832; http://dx.doi.org/10.1007/s00134-009-1748-1.
82. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr., Hite RD, Harabin AL; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-75; PMID:16714767; http://dx.doi.org/10.1056/NEJMoa062200.
83. Gao Smith F, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE; BALTI-2 study investigators. Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012; 379:229-35; PMID:22166903; http://dx.doi.org/10.1016/S0140-6736(11)61623-1.
84. Meyer KC, Prielipp RC, Grossman JE, Coursin DB. Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994; 78:772-4; PMID:8135399; http://dx.doi.org/10.1213/00000539-199404000-00027.
85. Lacomis D, Petrella JT, Giuliani MJ. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 1998; 21:610-7; PMID:9572240; http://dx.doi.org/10.1002/(SICI)1097-4598(199805)21:5610::AIDMUS73.0.CO;2-B
86. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, et al.; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363:1107-16; PMID:20843245; http://dx.doi.org/10.1056/NEJMoa1005372.
87. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, et al.; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-97; PMID:19318384; http://dx.doi.org/10.1056/NEJMoa0810625.
88. Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, Freire AX, Geehan D, Kohl B, Nasraway SA, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012; 40:3251-76; PMID:23164767; http://dx.doi.org/10.1097/CCM.0b013e3182653269.
89. Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005; 33:2778-85; PMID:16352960; http://dx.doi.org/10.1097/01.CCM.0000189939.10881.60.
90. Hoedemaekers CW, Klein Gunnewiek JM, Prinsen MA, Willems JL, Van der Hoeven JG. Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med 2008; 36:3062-6; PMID:18824915; http://dx.doi.org/10.1097/CCM.0b013e318186ffe6.
91. Khan AI, Vasquez Y, Gray J, Wians FH Jr., Kroll MH. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med 2006; 130:1527-32; PMID:17090196.
92. Guérin C, Girard R, Selli JM, Ayzac L. Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey. Intensive Care Med 2002; 28:1411-8; PMID:12373465; http://dx.doi.org/10.1007/s00134-002-1433-0.
93. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, Linde-Zwirble WT. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002; 28:29-37; PMID:11818996; http://dx.doi.org/10.1007/s00134-001-1159-4.
94. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002; 40:875-85; PMID:12407631; http://dx.doi.org/10.1053/ajkd.2002.36318.
95. Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, Kaplan RM; Collaborative Group for Treatment of ARF in the ICU. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60:1154-63; PMID:11532112; http://dx.doi.org/10.1046/j.1523-1755.2001.0600031154.x
96. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, Pallot JL, Chiche JD, Taupin P, Landais P, et al.; Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006; 368:379-85; PMID:16876666; http://dx.doi.org/10.1016/S0140-6736(06)69111-3.
97. Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med 1990; 112:492-8; PMID:2156475; http://dx.doi.org/10.7326/0003-4819-112-7-492.
98. Mathieu D, Neviere R, Billard V, Fleyfel M, Wattel F. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 1991; 19:1352-6; PMID:1935152; http://dx.doi.org/10.1097/00003246-199111000-00008.
99. Belch JJ, Lowe GD, Ward AG, Forbes CD, Prentice CR. Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 1981; 26:115-7; PMID:7291971.
100. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, et al.; Prophylaxis in Medical Patients with Enoxaparin Study Group. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999; 341:793-800; PMID:10477777; http://dx.doi.org/10.1056/NEJM199909093411103.
101. Cook D, Meade M, Guyatt G, Walter S, Heels-Ansdell D, Warkentin TE, Zytaruk N, Crowther M, Geerts W, Cooper DJ, et al.; PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 2011; 364:1305-14; PMID:21417952; http://dx.doi.org/10.1056/NEJMoa1014475.
102. King CS, Holley AB, Jackson JL, Shorr AF, Moores LK. Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis. Chest 2007; 131:507-16; PMID:17296655; http://dx.doi.org/10.1378/chest.06-1861.
103. Vanek VW. Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thigh-high to knee-high sleeves. Am Surg 1998; 64:1050-8; PMID:9798767.
104. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl 2):7S-47S.
105. Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, Tryba M. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996; 275:308-14; PMID:8544272; http://dx.doi.org/10.1001/jama.1996.03530280060038.
106. Lin PC, Chang CH, Hsu PI, Tseng PL, Huang YB. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med 2010; 38:1197-205; PMID:20173630; http://dx.doi.org/10.1097/CCM.0b013e3181d69ccf
107. Pongprasobchai S, Kridkratoke S, Nopmaneejumruslers C. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis. J Med Assoc Thai 2009; 92:632-7; PMID:19459523.
108. Gramlich L, Kichian K, Pinilla J, Rodych NJ, Dhaliwal R, Heyland DK. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition 2004; 20:843-8; PMID:15474870; http://dx.doi.org/10.1016/j.nut.2004.06.003.
109. Dhaliwal R, Jurewitsch B, Harrietha D, Heyland DK. Combination enteral and parenteral nutrition in critically ill patients: harmful or beneficial? A systematic review of the evidence. Intensive Care Med 2004; 30:1666-71; PMID:15185069; http://dx.doi.org/10.1007/s00134-004-2345-y
110. Simpson F, Doig GS. Parenteral vs. enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle. Intensive Care Med 2005; 31:12-23; PMID:15592814; http://dx.doi.org/10.1007/s00134-004-2511-2.
111. Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011; 365:506-17; PMID:21714640; http://dx.doi.org/10.1056/NEJMoa1102662.
112. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999; 27:2799-805; PMID:10628629; http://dx.doi.org/10.1097/00003246-199912000-00032.
113. Montejo JC, Zarazaga A, López-Martínez J, Urrútia G, Roqué M, Blesa AL, Celaya S, Conejero R, Galbán C, García de Lorenzo A, et al.; Spanish Society of Intensive Care Medicine and Coronary Units. Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr 2003; 22:221-33; PMID:12765660; http://dx.doi.org/10.1016/S0261-5614(03)00007-4.
114. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 2008; 34:1980-90; PMID:18626628; http://dx.doi.org/10.1007/s00134-008-1213-6.
115. Lee Char SJ, Evans LR, Malvar GL, White DB. A randomized trial of two methods to disclose prognosis to surrogate decision makers in intensive care units. Am J Respir Crit Care Med 2010; 182:905-9; PMID:20538959; http://dx.doi.org/10.1164/rccm.201002-0262OC
116. Bertolini G, Boffelli S, Malacarne P, Peta M, Marchesi M, Barbisan C, Tomelleri S, Spada S, Satolli R, Gridelli B, et al. End-of-life decisionmaking and quality of ICU performance: an observational study in 84 Italian units. Intensive Care Med 2010; 36:1495-504; PMID:20464541; http://dx.doi.org/10.1007/s00134-010-1910-9.
117. Scheunemann LP, McDevitt M, Carson SS, Hanson LC. Randomized, controlled trials of interventions to improve communication in intensive care: a systematic review. Chest 2011; 139:543-54; PMID:21106660; http://dx.doi.org/10.1378/chest.10-0595.
118. Schorr C, Dellinger RP. Performance improvement in the management of severe sepsis. In: Atualizaçao Em Medicina Intensiva. Valter Nilton Felix (eds). São Paulo, Ed. Do Autor, 2010:23-27.
119. Schorr C. Performance improvement in the management of sepsis. Crit Care Clin 2009; 25:857-67; PMID:19892257; http://dx.doi.org/10.1016/j. ccc.2009.06.005.
120. Townsend SR, Schorr C, Levy MM, Dellinger RP. Reducing mortality in severe sepsis: the Surviving Sepsis Campaign. Clin Chest Med 2008; 29:721-33, x; PMID:18954706; http://dx.doi.org/10.1016/j.ccm.2008.06.011.
121. Gao F, Melody T, Daniels DF, Giles S, Fox S. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 2005; 9:R764-70; PMID:16356225; http://dx.doi.org/10.1186/cc3909.
122. Pestaña D, Espinosa E, Sangüesa-Molina JR, Ramos R, Pérez-Fernández E, Duque M, Martínez-Casanova E; REASEP Sepsis Study Group. Compliance with a sepsis bundle and its effect on intensive care unit mortality in surgical septic shock patients. J Trauma 2010; 69:1282-7; PMID:20134352; http://dx.doi.org/10.1097/TA.0b013e3181c4539f
123. Levy MM, Pronovost PJ, Dellinger RP, Townsend S, Resar RK, Clemmer TP, Ramsay G. Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 2004; 32(Suppl):S595-7; PMID:15542969; http://dx.doi.org/10.1097/01.CCM.0000147016.53607.C4.
124. Barochia AV, Cui X, Vitberg D, Suffredini AF, O'Grady NP, Banks SM, Minneci P, Kern SJ, Danner RL, Natanson C, et al. Bundled care for septic shock: an analysis of clinical trials. Crit Care Med 2010; 38:668-78; PMID:20029343; http://dx.doi.org/10.1097/CCM.0b013e3181cb0ddf
125. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-6; PMID:12682500; http://dx.doi.org/10.1097/01.CCM.0000050454.01978.3B
126. Schorr C. Value of protocolization and sepsis performance improvement programs in early identification of sepsis handbook: early diagnosis of sepsis. In: Dellinger P, Carlet J, editors. Sepsis Handbook: Early Diagnosis of Sepsis. France: Biomerieux Education; 2007. p. 130-9.